249 related articles for article (PubMed ID: 18689688)
1. Glycan microarray of Globo H and related structures for quantitative analysis of breast cancer.
Wang CC; Huang YL; Ren CT; Lin CW; Hung JT; Yu JC; Yu AL; Wu CY; Wong CH
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11661-6. PubMed ID: 18689688
[TBL] [Abstract][Full Text] [Related]
2. Carbohydrate microarray for profiling the antibodies interacting with Globo H tumor antigen.
Huang CY; Thayer DA; Chang AY; Best MD; Hoffmann J; Head S; Wong CH
Proc Natl Acad Sci U S A; 2006 Jan; 103(1):15-20. PubMed ID: 16373501
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring anti-glycan antibodies binding to Globo H-expressing cells identify ovarian cancer patients.
Pochechueva T; Alam S; Schötzau A; Chinarev A; Bovin NV; Hacker NF; Jacob F; Heinzelmann-Schwarz V
J Ovarian Res; 2017 Feb; 10(1):8. PubMed ID: 28187738
[TBL] [Abstract][Full Text] [Related]
4. New development of glycan arrays.
Wu CY; Liang PH; Wong CH
Org Biomol Chem; 2009 Jun; 7(11):2247-54. PubMed ID: 19462030
[TBL] [Abstract][Full Text] [Related]
5. Development of Globo-H cancer vaccine.
Danishefsky SJ; Shue YK; Chang MN; Wong CH
Acc Chem Res; 2015 Mar; 48(3):643-52. PubMed ID: 25665650
[TBL] [Abstract][Full Text] [Related]
6. Affinity of monoclonal antibodies for Globo-series glycans.
Eller CH; Yang G; Ouerfelli O; Raines RT
Carbohydr Res; 2014 Oct; 397():1-6. PubMed ID: 25163606
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity study of Globo H analogues with modification at the reducing or nonreducing end of the tumor antigen.
Lee HY; Chen CY; Tsai TI; Li ST; Lin KH; Cheng YY; Ren CT; Cheng TJ; Wu CY; Wong CH
J Am Chem Soc; 2014 Dec; 136(48):16844-53. PubMed ID: 25371992
[TBL] [Abstract][Full Text] [Related]
8. Combined Effect of Anti-SSEA4 and Anti-Globo H Antibodies on Breast Cancer Cells.
Lee RH; Wang YJ; Lai TY; Hsu TL; Chuang PK; Wu HC; Wong CH
ACS Chem Biol; 2021 Aug; 16(8):1526-1537. PubMed ID: 34369155
[TBL] [Abstract][Full Text] [Related]
9. Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis.
Chang WW; Lee CH; Lee P; Lin J; Hsu CW; Hung JT; Lin JJ; Yu JC; Shao LE; Yu J; Wong CH; Yu AL
Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11667-72. PubMed ID: 18685093
[TBL] [Abstract][Full Text] [Related]
10. The Glycan Array Platform as a Tool to Identify Carbohydrate Antigens.
Xia L; Gildersleeve JC
Methods Mol Biol; 2015; 1331():27-40. PubMed ID: 26169733
[TBL] [Abstract][Full Text] [Related]
11. Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.
Hakomori S
Adv Exp Med Biol; 2001; 491():369-402. PubMed ID: 14533809
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a mouse monoclonal IgG3 antibody to the tumor-associated globo H structure produced by immunization with a synthetic glycoconjugate.
Kudryashov V; Ragupathi G; Kim IJ; Breimer ME; Danishefsky SJ; Livingston PO; Lloyd KO
Glycoconj J; 1998 Mar; 15(3):243-9. PubMed ID: 9579801
[TBL] [Abstract][Full Text] [Related]
13. Profiling of serum antibodies with printed glycan array: room for data misinterpretation.
Obukhova P; Piskarev V; Severov V; Pazynina G; Tuzikov A; Navakouski M; Shilova N; Bovin N
Glycoconj J; 2011 Dec; 28(8-9):501-5. PubMed ID: 22057658
[TBL] [Abstract][Full Text] [Related]
14. Immunization of fucose-containing polysaccharides from Reishi mushroom induces antibodies to tumor-associated Globo H-series epitopes.
Liao SF; Liang CH; Ho MY; Hsu TL; Tsai TI; Hsieh YS; Tsai CM; Li ST; Cheng YY; Tsao SM; Lin TY; Lin ZY; Yang WB; Ren CT; Lin KI; Khoo KH; Lin CH; Hsu HY; Wu CY; Wong CH
Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13809-14. PubMed ID: 23908400
[TBL] [Abstract][Full Text] [Related]
15. Serum antibody screening by surface plasmon resonance using a natural glycan microarray.
de Boer AR; Hokke CH; Deelder AM; Wuhrer M
Glycoconj J; 2008 Jan; 25(1):75-84. PubMed ID: 18193481
[TBL] [Abstract][Full Text] [Related]
16. Comparison of printed glycan array, suspension array and ELISA in the detection of human anti-glycan antibodies.
Pochechueva T; Jacob F; Goldstein DR; Huflejt ME; Chinarev A; Caduff R; Fink D; Hacker N; Bovin NV; Heinzelmann-Schwarz V
Glycoconj J; 2011 Dec; 28(8-9):507-17. PubMed ID: 21948103
[TBL] [Abstract][Full Text] [Related]
17. Polyclonal antibodies from patients immunized with a globo H-keyhole limpet hemocyanin vaccine: isolation, quantification, and characterization of immune responses by using totally synthetic immobilized tumor antigens.
Wang ZG; Williams LJ; Zhang XF; Zatorski A; Kudryashov V; Ragupathi G; Spassova M; Bornmann W; Slovin SF; Scher HI; Livingston PO; Lloyd KO; Danishefsky SJ
Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2719-24. PubMed ID: 10716997
[TBL] [Abstract][Full Text] [Related]
18. Expression of tumor-associated Thomsen-Friedenreich antigen (T Ag) in Helicobacter pylori and modulation of T Ag specific immune response in infected individuals.
Klaamas K; Kurtenkov O; Rittenhouse-Olson K; Brjalin V; Miljukhina L; Shljapnikova L; Engstrand L
Immunol Invest; 2002; 31(3-4):191-204. PubMed ID: 12472179
[TBL] [Abstract][Full Text] [Related]
19. Application of microarrays for deciphering the structure and function of the human glycome.
Smith DF; Cummings RD
Mol Cell Proteomics; 2013 Apr; 12(4):902-12. PubMed ID: 23412570
[TBL] [Abstract][Full Text] [Related]
20. The terminal sialic acid of stage-specific embryonic antigen-4 has a crucial role in binding to a cancer-targeting antibody.
Soliman C; Chua JX; Vankemmelbeke M; McIntosh RS; Guy AJ; Spendlove I; Durrant LG; Ramsland PA
J Biol Chem; 2020 Jan; 295(4):1009-1020. PubMed ID: 31831622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
